Trimethylamine N-Oxide as a potential risk factor for non-communicable diseases: A systematic review

CONCLUSION: There is a dose-response relationship between TMAO levels and NCDs progression. Therefore, it can be studied as a therapeutic target or prognostic biomarker for dealing with NCDs.PMID:36330632 | DOI:10.2174/1871530323666221103120410

Source: Endocrine, Metabolic and Immune Disorders Drug Targets - November 4, 2022 Category: Endocrinology Authors: Zahra Hoseini Tavassol Hanieh-Sadat Ejtahed Bagher Larijani Shirin Hasani-Ranjbar Source Type: research